Exploring the structure-activity relationship of brevibacillin: Discovery of synthetic analogues with an extended spectrum of activity.

Brevibacillin is an antimicrobial lipopeptide produced by Brevibacillus laterosporus with promising activity against several clinically relevant Gram-positive pathogens, including antibiotic-resistant strains such as methicillin-resistant Staphylococ…

Preview only. Read the full abstract at the source